New Delhi

Akums Drugs & Pharmaceuticals Ltd., India’s largest Contract Development and Manufacturing Organization (CDMO), has announced robust financial results for the third quarter of FY26, driven by healthy growth across key business segments and improved operational efficiencies.

During Q3 FY26, the company reported strong momentum in its CDMO business, which recorded revenue growth of over 16 per cent, supported by double-digit volume expansion. The international branded formulations segment also showed a sharp recovery, more than doubling sequentially on the back of rising demand across major overseas markets.

Adjusted EBITDA for the quarter rose 21 per cent year-on-year to ₹147 crore. The improvement was attributed to better capacity utilisation, steady ramp-up of newer manufacturing facilities, tighter control over overheads and portfolio rationalisation. These measures also helped mitigate losses in the Active Pharmaceutical Ingredients (API) and trade generics segments.

Akums said its journey towards becoming a global manufacturing player continued during the quarter, marked by the receipt of European Union Good Manufacturing Practice (EU GMP) certification for two of its manufacturing facilities. This included the renewal of EU GMP approval for its Oral Solids plant and the grant of EU GMP certification for its Oral Liquids facility.

In addition, the company received its first approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for Rivaroxaban tablets, further strengthening its presence in regulated international markets.

Commenting on the developments, Sandeep Jain, Managing Director, said the EU GMP certifications underscore the strength of the company’s compliant infrastructure, robust quality systems and skilled workforce. “We remain focused on disciplined growth while steadily strengthening our footprint in regulated markets,” he said.

READ MORE: Pakistan's newest talent Usman Tariq is inspired by M S Dhoni

Sanjeev Jain, also Managing Director, said the company’s emphasis on operational excellence and disciplined expansion aligns with its long-term global vision, enabling Akums to expand responsibly and deepen partnerships worldwide.